Catalyst Wire Dossier Catalyst Wire Dossier

Efavirenz/Emtricitabine/Tenofovir Disoproxil KRKA

efavirenz; emtricitabine; tenofovir disoproxil succinate · KRKA, d.d.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Efavirenz/Emtricitabine/Tenofovir Disoproxil KRKA, covering 2025-01-22 to 2025-01-22. Get the full timeline:

Most recent: EMA Authorised: Efavirenz/Emtricitabine/Tenofovir disoproxil Krka (efavirenz;emtricitabine;tenofovir disoproxil succinate) — KRKA, d.d., Novo mesto

See pricing